Translocator Protein PET/CT in Various TSPO-Related Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Translocator Protein PET/CT in Various TSPO-Related Disease — Stella

Recruiting

Back to Neuroinflammation trials

Trial locations(2 sites)

China

The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui

Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality

Key details

Sponsor

Tianjin Medical University

Collaborators

Tianjin Medical University General Hospital

Enrollment target

~200 participants

Started

November 2018

Primary completion

December 2027

Age range

18 Years – 80 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov